More on WXXWY

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(OP:WXXWY)
Delayed: 11.64 -0.04 (0.34%)
Prev. Close $11.68  
Open$11.58 
52 Wk High$ 
52 Wk Low$ 
Day High$11.88 
Day Low$11.52 
P/E N/A  
EPS$ 
Volume36,971 

Friends, Peers and Foes (?): 2269:HK, 1FW2, FOLD, BNTX IFRX (more...)

Jul 28, 2026 10:28 PM WuXi Biologics Recognized by FTSE4Good for the Sixth Consecutive Year, Underscoring Value Creation Through Green CRDMO
Jul 27, 2026 07:43 AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$51.38 at Nomura/Instinet
Jul 14, 2026 06:31 AM Bernstein SocGen Group Starts Wuxi Biologics (2269:HK) (WXXWY) at Market Perform
Jul 13, 2026 07:58 AM Wuxi Biologics (2269:HK) (WXXWY) PT Raised to HK$51.90 at CLSA
Jul 9, 2026 03:31 AM WuXi Biologics' MFG8 Drug Substance Facility Secures FDA PLI Approval, Advancing Commercial Supply of a Potential Blockbuster Autoimmune Therapy
Jul 8, 2026 03:15 AM WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year
Jun 30, 2026 01:49 AM WuXi Biologics Receives Brazil ANVISA GMP Certification to Enable Global Commercial Manufacturing of Innovative Cancer Immunotherapy
Jun 24, 2026 02:39 AM WuXi Biologics' 25th Drug Substance Facility Completes First GMP Production, Manufacturing Process Execution with Zero Deviations
Jun 18, 2026 12:57 AM WuXi Biologics' Suzhou Biosafety Testing Center Received Fourth EMA GMP Certification, Enabling 19 Commercial Products for the European Market
Jun 8, 2026 04:10 AM WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
View All Articles

Entities mentioned with WXXWY

View All Entities